JP2017520275A5 - - Google Patents

Download PDF

Info

Publication number
JP2017520275A5
JP2017520275A5 JP2017516013A JP2017516013A JP2017520275A5 JP 2017520275 A5 JP2017520275 A5 JP 2017520275A5 JP 2017516013 A JP2017516013 A JP 2017516013A JP 2017516013 A JP2017516013 A JP 2017516013A JP 2017520275 A5 JP2017520275 A5 JP 2017520275A5
Authority
JP
Japan
Prior art keywords
tert
alkyl
benzyl
group
butyldiphenylsilyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017516013A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017520275A (ja
JP6801934B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2015/050509 external-priority patent/WO2015184544A1/en
Publication of JP2017520275A publication Critical patent/JP2017520275A/ja
Publication of JP2017520275A5 publication Critical patent/JP2017520275A5/ja
Application granted granted Critical
Publication of JP6801934B2 publication Critical patent/JP6801934B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017516013A 2014-06-04 2015-06-02 膵臓細胞の健康、生存を高め、移植転帰を改善するための抗老化グリコペプチドの使用 Active JP6801934B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462007626P 2014-06-04 2014-06-04
US62/007,626 2014-06-04
PCT/CA2015/050509 WO2015184544A1 (en) 2014-06-04 2015-06-02 Use of anti-aging glycopeptides to enhance pancreatic cell health, survival and improve transplant outcome

Publications (3)

Publication Number Publication Date
JP2017520275A JP2017520275A (ja) 2017-07-27
JP2017520275A5 true JP2017520275A5 (enExample) 2017-09-07
JP6801934B2 JP6801934B2 (ja) 2020-12-16

Family

ID=54765902

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017516013A Active JP6801934B2 (ja) 2014-06-04 2015-06-02 膵臓細胞の健康、生存を高め、移植転帰を改善するための抗老化グリコペプチドの使用

Country Status (8)

Country Link
US (4) US20150352155A1 (enExample)
EP (1) EP3152297A4 (enExample)
JP (1) JP6801934B2 (enExample)
KR (1) KR102411834B1 (enExample)
CN (1) CN106661549B (enExample)
AU (1) AU2015271608B9 (enExample)
NZ (1) NZ727749A (enExample)
WO (1) WO2015184544A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3407876B1 (en) 2016-01-27 2022-01-12 Protokinetix Inc. Use of anti-aging glycoprotein for enhancing survival of neurosensory precursor cells
SI3411047T1 (sl) 2016-02-04 2021-09-30 Czap Research And Development, Llc Sredstva za nadzorovano sproščeni in stratificirani kompleks vključitve ciklodekstrina
KR20220137037A (ko) * 2020-01-24 2022-10-11 프로토키네틱스 인코포레이티드 이식편의 면역 거부의 억제를 위한 항-노화 글리코펩타이드들의 사용
CN115568282A (zh) * 2020-03-10 2023-01-03 普罗托基尼蒂克有限公司 抗衰老糖肽治疗干眼症、视网膜退行性疾病或眼部炎症的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2878851B1 (fr) * 2004-12-02 2007-02-09 Inst Nat Sciences Appliq Composes c-glycopeptides gem-difluores, leur preparation et leur utilisation en cryochirurgie et/ou cryopreservation
FR2900656A1 (fr) * 2006-05-03 2007-11-09 Inst Nat Sciences Appliq Composes c-glycopeptides gem-difluores, leur preparation et leur utilisation notamment pour la preservation de materiaux biologiques

Similar Documents

Publication Publication Date Title
ES2665277T3 (es) Análogos de purina y su uso como agentes inmunosupresores
JP2017527532A5 (enExample)
JP2017520275A5 (enExample)
AU2016343803A8 (en) Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids
JP2016515561A5 (enExample)
JP2019532080A5 (enExample)
AU2021201251B2 (en) Antimicrobial compounds, compositions, and uses thereof
JP2017511360A5 (enExample)
JP2019515908A5 (enExample)
JP2006514021A5 (enExample)
US8691777B2 (en) Combination therapy
JP2017510610A5 (enExample)
AU2019355218B2 (en) Monomer and multimeric anti-HBV agents
JP2008535902A5 (enExample)
CA2571347A1 (en) Piperazine derivatives for the treatment of female sexual disorders
RU2016141405A (ru) (5,6-дигидро)пиримидо[4,5-е]индолизины
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она
JP2013518036A5 (enExample)
NZ736015A (en) Heterocyclicalkyl derivative compounds as selective histone deacetylase inhibitors and pharmaceutical compositions comprising the same
ES2691252T3 (es) Macrólidos de biarilo con puente en 6,11
MX2025005209A (es) Compuestos lipídicos y usos de los mismos
CA2722102A1 (en) Phenylpropionic acid derivative and use thereof
US20170360844A1 (en) Use of anti-aging glycopeptides to enhance pancreatic cell health survival and improve transplant outcome
US8076311B2 (en) Compositions and methods for modulating the immune system
JP2020502106A5 (enExample)